Company Filing History:
Years Active: 2022-2025
Title: Kwang-Il Lee: Innovator in Nucleic Acid Detection Technologies
Introduction
Kwang-Il Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of nucleic acid detection, with a focus on developing innovative methods for identifying specific genetic materials in samples. His work has implications for various applications, including medical diagnostics and research.
Latest Patents
Kwang-Il Lee holds 2 patents that showcase his expertise in nucleic acid technology. His latest patents include:
1. **Method for determining the presence or absence of BCG in a sample** - This invention relates to a method for determining the presence or absence of BCG in a sample comprising a nucleic acid molecule. The method can detect the individual presence of BCG and the co-presence of two thereof.
2. **Methods for preparing oligonucleotides for detecting target nucleic acid molecules in samples** - This invention provides technology for preparing oligonucleotides for detecting a target nucleic acid molecule in a sample. Unlike conventional methods, it offers a first oligonucleotide candidate group designed appropriately for the first selected nucleotide sequence of the target nucleic acid molecule as a standard.
Career Highlights
Kwang-Il Lee is currently associated with Seegene, Inc., a company known for its advancements in molecular diagnostics. His work at Seegene has allowed him to contribute to the development of cutting-edge technologies that enhance the accuracy and efficiency of genetic testing.
Collaborations
Kwang-Il Lee has collaborated with notable colleagues, including Gi-Seok Yoon and Jun-Seo Lee. These collaborations have fostered a productive environment for innovation and have led to the advancement of their shared goals in the field of nucleic acid detection.
Conclusion
Kwang-Il Lee is a distinguished inventor whose work in nucleic acid detection technologies has made a significant impact in the field. His innovative patents and contributions to Seegene, Inc. highlight his commitment to advancing medical diagnostics and research.